BiotechTube
Home/RDP Pharma/Dr. Michael Ahrweiler, PhD
DM

Dr. Michael Ahrweiler, PhD

Co-Founder, Chief Development Officer, Board Member

RDP Pharma

Therapeutic Areas

OncologyInfectious Disease

RDP Pharma Pipeline

DrugIndicationPhase
PromptDegrader™ PlatformPlatform for IDR-protein driven diseasesPre-clinical
E7 DegraderHPV-driven cancers (e.g., cervical)Pre-clinical
MYC DegraderMYC-driven cancersPre-clinical
CROMOCNext-generation Drug Delivery ModuleDiscovery/Pre-clinical
CP201Cancer (oral alkyl ether lipid)Discovery/Pre-clinical

Leadership Team at RDP Pharma

PH
Peter Hertig
Chairman of the Board
DC
Dr. Christian Kühne, PhD
Founder, Chief Scientific Officer, Board Member
View full RDP Pharma profile